Cart
sales@molnova.com
lavendustin C
CAS No. 125697-93-0
lavendustin C( Lavendustin C | HDBA, NSC 666251 )
Catalog No. M17229 CAS No. 125697-93-0
Lavendustin C is a potent inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 48 | In Stock |
|
| 5MG | 80 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 330 | In Stock |
|
| 50MG | 491 | In Stock |
|
| 100MG | 707 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namelavendustin C
-
NoteResearch use only, not for human use.
-
Brief DescriptionLavendustin C is a potent inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase.
-
DescriptionLavendustin C, also known as HDBA and NSC 666251, is a potent inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase with an IC50 value of 0.012 μM.. HDBA inhibits tyrosine kinase-associated neutrophil degranulation and superoxide generation.
-
In VitroLavendustin C (Compound 5) shows potent inhibitory activity, and it may be the core structure responsible for inhibition of tyrosine kinase. Lavendustin C (10-150 μM) inhibits tyrosine kinase-associated neutrophil degranulation and superoxide generation.
-
In Vivo——
-
SynonymsLavendustin C | HDBA, NSC 666251
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
Recptortyrosine kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number125697-93-0
-
Formula Weight275.26
-
Molecular FormulaC14H13NO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (363.29 mM)
-
SMILESO=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O
-
Chemical Name5-[[(2,5-dihydroxyphenyl)methyl]amino]-2-hydroxy-benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nynca A, et al. Domest Anim Endocrinol. 2013 Jan;44(1):10-8
molnova catalog
related products
-
Dabrafenib
Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.
-
SB408124
SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.
-
R18
Antagonist of 14.3.3 proteins (KD ≈80 nM). Competitively inhibits 14.3.3-ligand interactions without requiring phosphorylation. Blocks the ability of 14.3.3 to bind to target proteins such as Raf-1, Bad, ASK1 and exoenzyme S.
